XML 59 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital
Retained Earnings
Unearned ESOP Shares
Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Jun. 30, 2022   15,591,466        
Balance at beginning of period at Jun. 30, 2022 $ 388,845 $ 156 $ 126,106 $ 270,276 $ (5,290) $ (2,403)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 9,199     9,199    
Cash dividends declared on common stock (1,355)     (1,355)    
Forfeited restricted stock (in shares)   (400)        
Retired stock (in shares)   (4,079)        
Retired stock $ (95)   (95)      
Granted restricted stock (in shares)   4,500        
Stock issued for RSUs (in shares)   13,861        
Exercised stock options (in shares) 27,000 27,000        
Exercised stock options $ 388   388      
Share-based compensation expense 567   567      
ESOP compensation expense 319   187   132  
Other comprehensive income (loss) (1,646)         (1,646)
Balance at end of period (in shares) at Sep. 30, 2022   15,632,348        
Balance at end of period at Sep. 30, 2022 $ 396,222 $ 156 127,153 278,120 (5,158) (4,049)
Balance at beginning of period (in shares) at Jun. 30, 2023 17,366,673 17,366,673        
Balance at beginning of period at Jun. 30, 2023 $ 471,186 $ 174 171,222 308,651 (4,761) (4,100)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 14,833     14,833    
Cash dividends declared on common stock (1,685)     (1,685)    
Forfeited restricted stock (in shares)   (1,630)        
Retired stock (in shares)   (5,730)        
Retired stock $ (133)   (133)      
Granted restricted stock (in shares)   1,000        
Stock issued for RSUs (in shares)   18,494        
Exercised stock options (in shares) 1,500 1,500        
Exercised stock options $ 24   24      
Share-based compensation expense 383   383      
ESOP compensation expense 299   167   132  
Other comprehensive income (loss) $ (496)         (496)
Balance at end of period (in shares) at Sep. 30, 2023 17,380,307 17,380,307        
Balance at end of period at Sep. 30, 2023 $ 484,411 $ 174 $ 171,663 $ 321,799 $ (4,629) $ (4,596)